文献速递围术期管理与 ERAS

糖尿病患者在加速康复胸腔镜肺叶切除术后的结局

Postoperative outcomes in patients with diabetes after enhanced recovery thoracoscopic lobectomy.
PubMed 文献 · Surg Endosc · 2024-06-07

该研究基于2012至2022年丹麦东部前瞻性数据库,回顾性分析3164例连续非选择的加速康复(ERAS)胸腔镜肺叶切除术患者,其中323例合并糖尿病。术前HbA1c水平与术后结局无相关性。

要点

  • 在ERAS环境下,糖尿病未增加胸腔镜肺叶切除术后的住院时间、并发症和再入院风险。
  • 糖尿病组30天和90天死亡率显著更高,可能与术前合并症较多有关。
  • 术前HbA1c水平与术后结局无相关性。

核心结论

  • 在ERAS环境下,糖尿病可能不增加胸腔镜肺叶切除术后住院时间延长、并发症和再入院的风险,但30天和90天死亡率更高,可能与术前合并症更多有关。

研究设计与样本

  • 回顾性分析2012至2022年丹麦东部前瞻性数据库中连续非选择的ERAS胸腔镜肺叶切除术患者,共纳入3164例,其中323例合并糖尿病。

主要发现

  • 中位住院时间为3天,研究期间保持稳定。
  • 糖尿病组与非糖尿病组在住院时间、术后并发症、再入院或30天院外存活方面无差异。
  • 术前HbA1c水平与术后结局无相关性。

临床怎么用

  • 在ERAS胸腔镜肺叶切除术围术期管理中,糖尿病本身不应作为延迟出院或延长观察的主要依据,但需重视糖尿病患者的术前合并症评估与术后30至90天随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes is considered a general surgical risk factor, but with few data from enhanced recovery (ERAS) otherwise known to improve outcome. Therefore, this study aimed to investigate postoperative outcomes of patients with diabetes who underwent video-assisted thoracoscopic surgery (VATS) lobectomy in an established ERAS setting. METHODS: We retrospectively analysed outcome data (hospital stay (LOS), readmissions, and mortality) from a prospective database with consecutive unselected ERAS VATS lobectomies from 2012 to 2022. Complete follow-up was secured by the registration system in East Denmark. RESULTS: We included 3164 patients of which 323 had diabetes, including 186 treated with insulin and antidiabetic medicine, 35 with insulin only and 102 with antidiabetic medicine only. The median LOS was 3 days, stable over the study period. There were no differences in terms of LOS, postoperative complications, readmissions or 30 days alive and out of hospital. Patients with diabetes had significantly higher 30- and 90-day mortality rates compared to those without diabetes (p < .001), but also had higher preoperative comorbidity. Preoperative HbA1c levels did not correlate with postoperative outcomes. CONCLUSION: In an ERAS setting, diabetes may not increase the risk for prolonged LOS, complications, and readmissions after VATS lobectomy, however with higher 30- and 90-day mortality probably related to more preoperative comorbidities.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Huang L, Petersen RH, Kehlet H, et al. Postoperative outcomes in patients with diabetes after enhanced recovery thoracoscopic lobectomy. Surg Endosc. 2024. PMID: 38849653. doi:10.1007/s00464-024-10936-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。